K-numberK243965
Device nameOrigin™
ApplicantNerv Technology Inc. (D.B.A.) Fluidai Medical
Product codeSFO
Device classClass II
Decision dateAug 21, 2025
DecisionSubstantially Equivalent
Regulation862.1120
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Origin™ system is an inline biosensor that continuously monitors the pH of surgical wound drainage fluid during postoperative recovery in hospitals. It consists of an inline device placed between a drainage catheter and reservoir, connected via Bluetooth to a mobile app that displays and analyzes the pH data. The device provides additional information on effluent characteristics but is not intended to diagnose or treat any clinical condition.

Technological characteristics

Origin™ uses an ion-sensitive field-effect transistor (ISFET) pH electrode with Ag/AgCl reference and 1-point liquid calibration, versus the predicate's glass ion-sensitive electrode (ISE) with 2-point calibration. Origin™ measures continuously from drain effluent (5-9 pH range) with 0.01 pH resolution on a battery-powered point-of-care device, whereas the predicate measures discrete samples (7-7.5 pH) with 0.001 pH resolution in a wall-powered laboratory setting. Both use potentiometric pH measurement principles.

Test standards cited

IEC 62304:2006, IEC 60601-1:2005, IEC 60601-1-2:2014, IEC 61010-1:2010, IEC 61326-2-6:2020. CLSI EP05-A3 (precision), EP06 (linearity), EP07 (interference), EP09c (method comparison), EP37, and EP39 were referenced for analytical testing.

Substantial equivalence argument

Both devices measure pH using potentiometric measurement with the same reference electrode, and the submission demonstrates equivalent analytical performance through precision testing (repeatability and within-lab precision <2.1% CV), linearity across the operating range (≤0.1446 pH units deviation), absence of significant interference from clinically relevant substances, and method comparison showing strong correlation (r² ≥0.576) with acceptable bias (≤0.251 pH units). Although Origin™ differs by using ISFET technology, continuous sampling, and point-of-care deployment versus the predicate's discrete laboratory measurements, the submission argues these differences do not raise new safety or efficacy questions because the underlying measurement principle is the same and analytical performance is demonstrated as equivalent.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →